Cooper Pharma Tit Mellil plant
The factory occupies an area of 20,000 square meters and has about 500 employees. The Tit Mellil unit ensures manufacturing of injectables, solids, liquids and paste forms. The site is certified ISO 9001: 2000, GMP, AFSSAPS and Saudi FDA. About 45 million units produced in 2018. This site works with an ongoing process of continuous improvement of its capabilities with the renewal of equipments at the cutting edge of technology.
Cooper Pharma holds a strategic participation in MC Pharma.
This industrial site, operational in 2019, will be the first site dedicated to the manufacturing of contraceptive hormones.
Cooper East Africa
Under construction phase in Kigali, Rwanda.